XML 27 R25.htm IDEA: XBRL DOCUMENT

19. Parent Company Financial Statements (Unaudited)

12 Months Ended

Dec. 31, 2012

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

19. Parent Company Financial Statements (Unaudited)

19. Parent Company Financial Statements (Unaudited)

The following is a summary of the Parent Company financial statements for the years ended December 31, 2012 and 2011:

Aemetis, Inc. (Parent Company)

Consolidated Condensed Balance Sheets

As of December 31, 2012 and 2011

Assets	2012			2011
Current assets
Cash and cash equivalents	$	-		$	747
Intercompany receivables		20,802,877			3,168,587
Prepaid expenses		-			88,000
Total current assets		20,802,877			3,257,334

Investments in Subsidiaries, net of advances
Investment in Aemetis International, Inc.		3,060,684			5,979,020
Investment in Aemetis Americas, Inc		116,144			-
Total investments in Subsidiaries, net of advances		3,176,828			5,979,020

Other assets		23,095			23,095
Total Assets	$	24,002,800		$	9,259,449

Liabilities & stockholders' deficit
Current liabilities
Accounts payable	$	4,037,137		$	3,800,250
Outstanding checks in excess of cash		25,773			-
Mandatorily redeemable Series B convertibe preferred		2,437,649			2,320,164
Secured notes, net of discount for issuance cost		-			1,075,588
Other current liabilities		2,174,608			1,786,962
Total current liabilities		8,675,167			8,982,964

Parent Company long term debt portion of secured notes, net of discount for issuance cost		-			6,016,926

Subsidiary obligation in excess of investment
Investment in AE Advanced Fuels, Inc.		8,400,675			13,253,011
Investment in Aemetis Americas, Inc		-			118,252
Investment in Aemetis Biofuels, Inc.		2,624,575			2,567,894
Investment in Aemetis Technologies, Inc.		438,375			174,488
Investment in Biofuels Marketing, Inc.		349,056			348,996
Total subsidiary obligation in excess of investment		11,812,681			16,462,641

Total long term liabilities		11,812,681			22,479,567

Stockholders' equity/(deficit)
Series B Preferred convertible stock		3,098			3,115
Common stock		180,281			130,747
Additional paid-in capital		75,457,760			45,432,447
Accumulated deficit		(69,808,294	)		(65,526,029	)
Accumulated other comprehensive loss		(2,317,893	)		(2,243,362	)
Total stockholders' equity/(deficit)		3,514,952			(22,203,082	)
Total liabilities & stockholders' deficit	$	24,002,800		$	9,259,449

Aemetis, Inc. (Parent Company)

Consolidated Statements of Operations and Comprehensive Loss

For the Years Ended December 31, 2012 and 2011

	2012			2011

Equity in subsidiary earnings/(losses)	$	(12,496	)	$	(15,386,811	)

Selling, general and administrative expenses		2,302,944			1,003,879

Operating loss		(2,315,440	)		(16,390,690	)

Other income/(expense)
Interest expense		(1,865,803	)		(1,918,750	)
Other income/(expense)		(97,022	)		16,281

Loss before income taxes		(4,278,265	)		(18,293,159	)

Income taxes benefit/(expense)		(4,000	)		(3,200	)

Net loss	$	(4,282,265	)	$	(18,296,359	)

Other comprehensive loss
Foreign currency translation adjustment		(74,531	)		(1,372,441	)
Comprehensive loss	$	(4,356,796	)	$	(19,668,800	)

Aemetis, Inc. (Parent Company)

Consolidated Statements of Cash Flows

For the years ended December 31, 2012 and 2011

	2012			2011
Operating activities:
Net loss		(4,282,265	)	$	(18,296,359	)
Adjustments to reconcile net loss to
net cash provided/(used) in operating activities:
Stock-based compensation		686,059			177,278
Depreciation and amortization		-			2,193
Amortization of debt issuance discount		400,997			1,177,413
Change in fair value of warrant liability		97,022
Changes in assets and liabilities:
Subsidiary portion of net losses		12,496			15,386,811
Prepaid expenses		4,668			1,160
Other current assets and other assets		-			1
Accounts payable		236,887			743,982
Accrued interest expense		682,983			894,475
Other liabilities		288,203			72,733
Net cash (used) in/provided by operating activities		(1,872,950	)		159,687

Investing activities:
Change in outstanding checks in excess of cash		25,773			-
Subsidiary advances, net		9,417,256			723,429
Net cash provided in investing activities		9,443,029			723,429

Financing activities:
Proceeds from borrowings under secured debt facilities		840,000			-
Repayments of borrowings under secured debt facilities		(8,412,259	)		(900,000	)
Warrants exercised		1,433			-
Net cash used by financing activities		(7,570,826	)		(900,000	)

Net decrease in cash and cash equivalents		(747	)		(16,884	)

Cash and cash equivalents at beginning of period		747			17,631
Cash and cash equivalents at end of period	$	-		$	747

Supplemental disclosures of cash flow information, cash paid:

Income taxes		4,000			3,200

Supplemental disclosures of cash flow information, non-cash transactions:

Issuance of shares for acquisition		12,511,200			1,890,135
Stock and warrants issued to pay interest and fees on borrowings		11,885,579			1,662,323
Payment of loans and fees by issuance of stock to related party		4,107,141			1,452,818
Beneficial conversion discount on related party debt		884,851			1,732,872

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References+ Details